Moreover, analysis of gene expression across pathological stages showed consistent upregulation of CDH1, CDH2, and CDH3 in advanced tumor stages, emphasizing the potential role of cadherin genes in NSCLC progression (Figs. 2E, 2F). This evidence concerns the gene CDH2 and non-small cell lung carcinoma.